References
- Madri J A, Basson MD. Extracellular matrix-cell interactions: dynamic modulators of cell, tissue and organism structure and function. Lab Invest 1992; 66: 519–21
- Timpl R. Review: Structure and biological activity of basement membrane proteins. Eur J Biochem 1989; 180: 487–502
- Bruijn J A, Hogendoorn P CW, Hoedemaeker P J, Fleuren GJ. The extracellular matrix in pathology-a review. J Lab Clin Med 1988; 66: 140–9
- Schilling V, Holly A, Buija J, Kastenbauer E. High levels of fibronectin in the stroma of aural cholesteatoma. Am J Otolaryngol 1995; 16: 232–5
- Lang S, Nerlich A, Wiest I, Schreiner M. Immunohis-tochemical analysis of the basement membrane in cholesteatoma epithelium. Laryngorhinootol 1994; 73: 371–4
- Chiquet-Ehrismann R, Mackie E J, Pearson C A, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986; 47: 131–9
- Schalkwijk J, Steijlen P M, van Vlijmen Willems I M, Oosterling B, Mackie E J, Verstraeten AA. Tenascin expression in human dermis is related to epidermal proliferation. Am J Pathol 1991; 139: 1143–50
- Key G, Becker M HG, Duchrow M, Schlüter C, Gerdes J. New Ki-67 equivalent murine monoclonal antibodies (MIB1-3) prepared against recombinant parts of the Ki-67 antigen. Anal Cell Pathol 1992; 4: 181
- Liotta L A, Rao C N, Barsky SH. Tumor invasion and the extracellular matrix. Lab Invest 1983; 49: 636–49
- Chiquet-Ehrismann R. Tenascin and other adhesion-modulating proteins in cancer. Cancer Biology 1993; 4: 301–10
- Frazier WA. Thrombospondins. Curr Opin Cell Biol 1991; 3: 792–9
- Mackie E J, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988; 107: 2557–67
- Hiraiwa N, Kida H, Sakakura T, Kusakabe M. Induction of tenascin in cancer cells by interactions with embryonic mesenchyme mediated by a diffusible factor. Cell Sci 1993; 104: 289–96
- Schalkwijk J, van Vlijmen I, Oosterling B, et al. Tenascin expression in hyperproliferative skin diseases. Br J Dermatol 1991; 124: 13–20
- Gerdes J, Lemke H, Baisch H, Wacker H H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710–15
- Pich A, Ponti R, Valente G, et al. MIB-1, Ki-67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. J Clin Pathol 1994; 47: 18–22
- Soini Y, Paakko P, Virtanen I, Letho V-P. Tenascin in salivary gland tumors. Virchows Arch A Pathol Anat 1992; 421: 217–22
- Castellucci M, Classen-Linke I, Miihlhauser J, Kauf-Mann P, Zardi L, Chiquet-Ehrismann R. The human placenta: a model for tenascin expression. Histochemistry 1991; 95: 449–58
- Mackie E J, Chiquet-Ehrismann R, Pearson C A, et al. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci USA 1987; 84: 4621–5
- Jones F S, Burgoon M P, Hoffman S, Crossin K L, Cunningham B A, Edelman GM. A cDNA clone for cyto-tactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. Proc Natl Acad Sci USA 1988; 85: 2186–90
- Engel J. EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation?. FEBS Lett 1989; 251: 1–7
- Habermann J. Zur Entstehung des Cholesteatoms des Mittelohres (Cysten in der Schleimhaut der Pauken-höhle, Atropine der Nerven in der Schnecke). Arch Ohrenheil 1889; 27: 42–50
- Bezold F. Cholesteatom, Perforation der Membrana flaccida Shrapnelli und Tubenverschluss, eine atiologi-sche Studie. Z Ohrenheilkunde 1890; 20: 5–28
- Manasse P, Grunberg K, Lange W. Handbuch der pathologischen Anatomie des menschlichen Ohres. JF Bergmann, Wiesbaden 1917